D

DEFYMED

17 employees

Defymed is a leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Health Care
MailPan®
Cell therapy
Bioartificial Pancreas
ExOlin®
Medical Devices
Diabetes
Insulin delivery device
Cell encapsulation
Bioartificial Organs

Date founded

2011

Funding rounds raised

Total raised

$2.8M

from 6 investors over 6 rounds

D

DEFYMED raised $2.8M on October 27, 2015

Investors: Centre européen d'étude du Diabète - CeeD and EMERTEC

D

DEFYMED raised $1.6M on October 4, 2013

Investors: EMERTEC and Centre européen d'étude du Diabète - CeeD

D

DEFYMED raised undisclosed on April 4, 2011

Investors: Centre européen d'étude du Diabète - CeeD and STATICE Innovation

FAQ